VERALOX THERAPEUTICS Trademark

Trademark Overview

On Thursday, May 19, 2022, a trademark application was filed for VERALOX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the VERALOX THERAPEUTICS trademark a serial number of 97419155. The federal status of this trademark filing is SU - NON-FINAL ACTION - MAILED as of Wednesday, April 9, 2025. This trademark is owned by Veralox Therapeutics Inc.. The VERALOX THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, chemical and small molecule preparations for use in treatment of blood disorders; pharmaceutical formulations for treatment of blood disorders
veralox therapeutics

General Information

Serial Number97419155
Word MarkVERALOX THERAPEUTICS
Filing DateThursday, May 19, 2022
Status807 - SU - NON-FINAL ACTION - MAILED
Status DateWednesday, April 9, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements

Goods and ServicesPharmaceutical products, namely, chemical and small molecule preparations for use in treatment of blood disorders; pharmaceutical formulations for treatment of blood disorders
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, May 25, 2022
Primary Code005
First Use Anywhere DateMonday, July 31, 2023
First Use In Commerce DateMonday, July 31, 2023

Trademark Owner History

Party NameVeralox Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFrederick, MD 21703
Party NameVeralox Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFrederick, MD 21704

Trademark Events

Event DateEvent Description
Wednesday, March 8, 2023ASSIGNED TO EXAMINER
Monday, May 23, 2022NEW APPLICATION ENTERED
Wednesday, May 25, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 16, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, March 16, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, March 16, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, March 16, 2023EXAMINER'S AMENDMENT ENTERED
Thursday, March 16, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 12, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, December 11, 2023SOU TEAS EXTENSION RECEIVED
Monday, December 11, 2023SOU EXTENSION 1 FILED
Monday, December 11, 2023SOU EXTENSION 1 GRANTED
Tuesday, December 12, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, December 12, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, February 12, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 13, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 8, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 8, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 8, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, February 12, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, February 12, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, May 15, 2024SOU EXTENSION 2 FILED
Wednesday, May 15, 2024SOU EXTENSION 2 GRANTED
Wednesday, May 15, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 10, 2024USE AMENDMENT FILED
Tuesday, December 10, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, December 10, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 10, 2024SOU EXTENSION 3 FILED
Thursday, May 16, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 10, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, December 10, 2024SOU EXTENSION 3 GRANTED
Friday, February 21, 2025STATEMENT OF USE PROCESSING COMPLETE
Friday, February 21, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, April 9, 2025SU - NON-FINAL ACTION - WRITTEN
Wednesday, April 9, 2025NON-FINAL ACTION E-MAILED
Wednesday, April 9, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED

Related Keywords

therapeutics veralox treatment pharmaceutical blood disorders formulations preparations molecule products namely chemical